Business Wire

Mitsui Chemicals Catalysis Science Awards Celebrate 20-year Milestone

27.3.2025 14:00:00 CET | Business Wire | Press Release

Share

Mitsui Chemicals Catalysis Science Awards were established by Mitsui Chemicals in 2004 to recognize researchers who have made outstanding contributions to the progress in catalysis science.
The awards consist of the Catalysis Science Award (the main award eligible for 47 years old or below) and the Catalysis Science Award for Creative Work (for younger generation at 37 years old or below).
The awards are highly respected. The 2011 Catalysis Science Award winner later received the Nobel Prize in Chemistry in 2021.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250327014324/en/

2024 Mitsui Chemicals Catalysis Science Award Ceremony

Now in its 10th iteration, the 2024 awards were presented to the winners with a commemorative plaque and certificate at the award ceremony held in Tokyo on October 24, 2024.

The 2024 Award Winners

  • Winner of the 2024 Mitsui Chemicals Catalysis Science Award:
    Guangbin Dong, Weldon G. Brown Professor of Chemistry, The University of Chicago (front row, center)
  • Winners of the 2024 Mitsui Chemicals Catalysis Science Award for Creative Work:
    Ming Joo Koh, Associate Professor, National University of Singapore (front row, right)
    Keary M. Engle, Professor, The Scripps Research Institute (front row, left)

As a chemical manufacturer for whom catalysts are indispensable, Mitsui Chemicals remains committed to continuously support these awards as a tribute to researchers in catalysis science and contribute to the sustainable development of chemistry and the chemical industry.

Mitsui Chemicals will begin accepting applications for the 2026 Catalysis Science Awards this September.
The awards are expected to attract significant participation from researchers specializing in catalysis science.

Mitsui Chemicals Catalysis Science Awards

View source version on businesswire.com: https://www.businesswire.com/news/home/20250327014324/en/

Contacts

For inquiries about this matter, please contact:
Mitsui Chemicals Catalysis Science Award Office
Mitsui Chemicals, Inc.
E-mail address for inquiries: mci-award@mitsuichemicals.com
Inquiry Form -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fform.mitsuiche
micals.com%2Fcorporate%2Fcc_pr_csr_en%3Fparam%3D7%26_gl%3D1*y8w9q1*_gcl_au*NDUzN
zQzOTM3LjE3Mzk3NjA5MTE.%26_ifbs-cc_common_inquiry_en%3Ds1_Step1%26_ifbs-common_f
ooter%3Ds1_Step1%26_ifbs-common_header_en%3Ds1_Step1&esheet=54228933&newsitemid=
20250327014324&lan=en-US&anchor=Inquiry+Form&index=2&md5=01a91034fdceb6c6328a32f
33282e30c

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex to Present New Data on ALYFTREK ® at the North American Cystic Fibrosis Conference9.10.2026 19:15:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine pancreatic function represent a profound shift in how we understand the benefits of treating cystic fibrosis in its earliest stages,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Devel

Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment9.10.2026 16:00:00 CEST | Press Release

Verdant Rock Limited, a Bermuda Monetary Authority-regulated Class 3B insurance company, has received an A (low) Financial Strength Rating from Morningstar DBRS. The rating reflects Verdant Rock’s financial strength and its capacity to meet policyholder obligations as an investment-grade financial guarantor for Emerging Markets credit. Morningstar DBRS is a global credit rating agency with coverage across North America, Europe, Asia, and Latin America. Its assessment of Verdant Rock reflects the company’s strong projected earnings ability, robust risk profile, sound liquidity, and good capitalization. Morningstar DBRS also assigned an A (low) Issuer Rating to Verdant Rock. The rating follows Verdant Rock’s BBB+ Long-Term Insurer Financial Strength Rating with a Stable Outlook from Fitch Ratings, assigned on 12 June 2026. Verdant Rock now holds Financial Strength Ratings from both Fitch Ratings and Morningstar DBRS, providing counterparties with dual-agency confirmation of the company’s

Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions9.10.2026 15:17:00 CEST | Press Release

Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced that Gartner has positioned it as a Visionary in the first-ever Magic Quadrant for AI-Enabled CSP Marketing and Sales Solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009905430/en/ Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions A new category for a new operating model. CSPs are fighting saturated markets, rising acquisition costs, and accelerating churn. They are responding with AI-driven automation across the full revenue cycle, from segmentation and campaigns to lead management, CPQ, and renewals, increasingly executed by autonomous agents. According to us, Gartner creation of this Magic Quadrant confirms the shift has moved from pilot to boardroom priority. According to Gartner, Visionaries "understands where the market

Positive New Data on Corcym’s Perceval Plus Sutureless Aortic Heart Valve Encompasses up to 7-Year Follow-up9.10.2026 15:15:00 CEST | Press Release

Corcym, a global medical device company dedicated to cardiac surgery, today announced that positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve as part of its MANTRA clinical trial was featured in an oral presentation today at the annual meeting of the European Association for Cardio-Thoracic Surgery (EACTS). The study is the longest follow-up available for Perceval Plus and the FREE tissue treatment from an international multicenter study, and demonstrated excellent durability, safety and quality of life improvements. Perceval Plus is the only sutureless and collapsible aortic surgical heart valve. Its unique design performs in any surgical scenario and is optimal for endoscopy and robotics. The valve features the company’s FREE next generation tissue treatment addressing the two main causes of calcification, phospholipids and aldehydes. Its proprietary LANCELOT advanced manufacturing process includes zero-pressure shaping and laser cutting of

Ada earns AWS Travel and Hospitality Competency for resolving traveler issues at scale9.10.2026 15:00:00 CEST | Press Release

Ada, the pioneer in Agentic Customer Experience, today announced it has achieved the Amazon Web Services (AWS) Travel and Hospitality Competency. The designation recognizes Ada as an AWS Partner with demonstrated technical proficiency and proven customer success helping travel and hospitality brands resolve customer issues at scale. Ada joins a select group of 58 AWS Partners holding the competency, and it reflects a shared commitment to helping travel brands deliver service that holds up on their busiest, most unpredictable days. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009673638/en/ Ada earns AWS Travel and Hospitality Competency for resolving traveler issues at scale "Travel is where agentic customer service gets tested hardest. Demand spikes without warning, policies change by the hour, and customers are often stressed and far from home," said Mike Murchison, CEO and co-founder of Ada. "Our airline and hospitali

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye